UroVation

Radiology & Theranostics in Castrate Resistant Prostate Cancer (CRPC)

Dr. Gamie explores PSMA imaging and theranostic advances in mCRPC.

WSAUA 2025: PSMA PET Imaging and Theranostics in Prostate Cancer: Current Landscape and Future Directions

PSMA PET and theranostics are transforming prostate cancer staging and treatment. Review current imaging tracers, Lu-177 therapy, and future alpha-emitter strategies.

WSAUA 2025: Micro-Ultrasound (Micro-US), MRI, and PSMA PET in Prostate Cancer: Whole-Mount Correlation Study

Micro-ultrasound matches MRI for prostate cancer detection in whole-mount analysis, confirming biopsy-based results from the OPTIMUM trial—while MRI remains best for extracapsular extension.

UroVation Interview: Envision Sciences – Advancing Cancer Diagnosis and Prognosis

GRU UroVations: Dr. Crawford and Steven Stone, PhD, Envision Sciences, Salt Lake City, Utah, discuss IHC Biomarkers in prostate cancer.